Browse Drug Recalls

2,191 FDA drug safety recalls.

FDA Drug Recall Enforcement Database

Browse 2,191 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.

Drug Safety Recalls

Browse 2,191 FDA drug recalls in NJ.

Clear
DateProductReasonClassFirm
May 28, 2026 CAREone, EXTRA STRENGTH CALCIUM ANTACID, Calcium Carbonate 750 mg, 96 chewabl... Presence of foreign substance: small metallic particles in chewable tablets. Class II Guardian Drug Co. Inc.
May 28, 2026 HyVee, Ultra Strength Antacid, Calcium Carbonate 1000 mg, 72 CHEWABLE TABLETS... Presence of foreign substance: small metallic particles in chewable tablets. Class II Guardian Drug Co. Inc.
May 28, 2026 HALEON CALCIUM CARBONATE TUMS ANTACID, Assorted Fruit Tablets, 1000 mg, 160-c... Presence of foreign substance: small metallic particles in chewable tablets. Class II Guardian Drug Co. Inc.
May 27, 2026 Alyacen 7/7/7, Norethindrone and Ethinyl Estradiol Tablets USP, 0.5mg/0.035mg... Failed Impurities/Degradation Specifications: This recall is being initiated due to out-of-specif... Class II Glenmark Pharmaceuticals Inc., USA
May 27, 2026 Aripiprazole Tablets USP, Rx only, 30 mg, 30 tablets, Marketed by: Ajanta Pha... Product Mix-Up: A bottle containing Voriconazole Tablets 50 mg was labelled and distributed as A... Class II Ajanta Pharma USA Inc
May 22, 2026 Xyvona (levorphanol tartrate tablets), 3mg, 100 Tablets, Rx only, Forte BioPh... Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by F... Class II SUN PHARMACEUTICAL INDUSTRIES INC
May 22, 2026 Xyvona (levorphanol tartrate tablets), 2mg, 100 Tablets, Rx only, Forte BioPh... Labeling: Not Elsewhere Classified. This recall has been initiated in response to the denial by F... Class II SUN PHARMACEUTICAL INDUSTRIES INC
May 21, 2026 Pearson Quality Topical Anesthetic Gel (20% Benzocaine), Mint Flavor, Net Con... Defective container:may contain bottles with incomplete seals Class II Keystone Industries
May 21, 2026 safco SensiCaine-Ultra (20% Benzocaine), Topical Anesthetic Gel, Strawberry F... Defective container:may contain bottles with incomplete seals Class II Keystone Industries
May 21, 2026 Dental City TOPICAL ANESTHETIC GEL, BENZOCAINE 20%, Strawberry Flavor, 1 OZ ... Defective container:may contain bottles with incomplete seals Class II Keystone Industries
May 21, 2026 Burkhart topical anesthetic gel, benzocaine 20 %, Strawberry Flavor, 1 oz (30... Defective container:may contain bottles with incomplete seals Class II Keystone Industries
May 21, 2026 Quala Dental Products, Topical Anesthetic Gel, 20 % Benzocaine, Strawberry Fl... Defective container:may contain bottles with incomplete seals Class II Keystone Industries
May 21, 2026 PureLife, TOPICAL ANESTHETIC GEL, BENZOCAINE 20%, 1 oz (30mL), Strawberry Fl... Defective container:may contain bottles with incomplete seals Class II Keystone Industries
May 21, 2026 DHP Topical Anesthetic Gel, Benzocaine 20%, Strawberry Flavor, 1 oz. (30 g), ... Defective container:may contain bottles with incomplete seals Class II Keystone Industries
May 18, 2026 Lidocaine HCl Injection, USP 2%, 40 mg/2 mL (20 mg/mL), 2 mL per Single-Dose ... Labeling: Not Elsewhere Classified: The label wrap covers the barcode, making it hard to scan Class III Eugia US LLC
May 12, 2026 DOXOrubin Hydrochloride Liposome injection, 50 mg/25 mL (2mg/mL), 25 mL singl... Presence of Particulate matter: Particulate matter identified as glass. Class I SUN PHARMACEUTICAL INDUSTRIES INC
May 11, 2026 Gas-X, Simethicone 125 mg/ ANTIGAS, 120 SoftGels, Distributed by: Haleon, War... Labeling: Not Elsewhere Classified- Incomplete inactive ingredient information on the carton labe... Class II Haleon US Holdings LLC
May 5, 2026 Amlodipine and Olmesartan Medoxomil Tablets, 5mg/40mg, Rx Only, 30-count bott... Failed Dissolution Specifications: Olmesartan Medoxomil content below specifications Class II Ascend Laboratories, LLC
Apr 29, 2026 Erythromycin Tablets, USP, 250 mg, 30 tablets per bottle, Rx only, Manufactur... CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable in... Class II Zydus Pharmaceuticals (USA) Inc
Apr 29, 2026 Erythromycin Tablets, USP, 500 mg, 30 tablets per bottle, Rx only, Manufactur... CGMP Deviations; presence of N-Nitroso-Desmethyl-Erythromycin above the recommended acceptable in... Class II Zydus Pharmaceuticals (USA) Inc
Apr 27, 2026 Ascend Laboratories, LLC, Metoprolol Succinate Extended-Release Tablets, USP,... Failed Dissolution Specifications Class II Ascend Laboratories, LLC
Apr 24, 2026 Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, ... Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food ... Class II Teva Pharmaceuticals USA, Inc
Apr 21, 2026 Duloxetine Delayed-Release Capsules USP, 60mg, Rx Only, 90-count bottle, Mfr... CGMP Deviations; presence of N-nitroso-duloxetine impurity above the FDA recommended limit Class II Breckenridge Pharmaceutical, Inc.
Apr 13, 2026 busPIRone Hydrochloride Tablets, USP, 5 mg, 500-count bottle, Rx Only, Manufa... Subpotent drug Class III Unichem Pharmaceuticals USA Inc.
Apr 6, 2026 Claravis (isotretinoin capsule, USP), 10 mg, Packaged as a) 100-count carton,... Failed Impurities/Degradation Specifications: Out of specification for specific impurity Tretinoin Class II Teva Pharmaceuticals USA, Inc
Mar 27, 2026 Prazosin Hydrochloride Capsules, USP, 5mg, 100-count bottle, Rx Only, Manufac... cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin im... Class II Appco Pharma LLC
Mar 27, 2026 Prazosin Hydrochloride Capsules, USP, 2mg, 100-count bottle, Rx Only, Manufa... cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin im... Class II Appco Pharma LLC
Mar 27, 2026 Prazosin Hydrochloride Capsules, USP, 1mg, 100-count bottle, Rx Only, Manufac... cGMP deviation: detection of Nitrosamine Drug Substance-Related Impurities, N-nitroso-prazosin im... Class II Appco Pharma LLC
Mar 25, 2026 Fluocinonide, USP, 0.05% Cream, 15g tube, Rx only, Mfd by: Taro Pharmaceutica... Failed Viscosity Specifications: Out of Specification results, above the specification limit, in... Class II SUN PHARMACEUTICAL INDUSTRIES INC
Mar 25, 2026 Fluocinonide, USP, 0.05% Cream, 60g tube, Rx only, Mfd by: Taro Pharmaceutica... Failed Viscosity Specifications: Out of Specification results, above the specification limit, in... Class II SUN PHARMACEUTICAL INDUSTRIES INC
Mar 25, 2026 Fluocinonide, USP, 0.05% Cream, 30g tube, Rx only, Mfd by: Taro Pharmaceutica... Failed Viscosity Specifications: Out of Specification results, above the specification limit, in... Class II SUN PHARMACEUTICAL INDUSTRIES INC
Mar 20, 2026 Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by... CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit. Class II Leading Pharma, LLC
Mar 19, 2026 Clonidine Transdermal System, USP, 0.3 mg/day, supplied in cartons of 4 Syste... CGMP Deviations: use of an unapproved raw material Class II Teva Pharmaceuticals USA, Inc
Mar 19, 2026 Clonidine Transdermal System, USP, 0.1 mg/day, supplied in cartons of 4 Syste... CGMP Deviations: use of an unapproved raw material Class II Teva Pharmaceuticals USA, Inc
Mar 19, 2026 Clonidine Transdermal System, USP, 0.2 mg/day, supplied in cartons of 4 Syste... CGMP Deviations: use of an unapproved raw material Class II Teva Pharmaceuticals USA, Inc
Mar 19, 2026 traMADol Hydrochloride Tablets, USP, 50 mg, 500-count bottles, Rx only, Manu... Failed Impurities/Degradation Specifications: N-nitroso-desmethyl-tramadol impurity (NDSRI) was f... Class II Amneal Pharmaceuticals, LLC
Mar 18, 2026 Magnesium Sulfate in Water for Injection, 4g/100 mL (40mg/mL) IV bag, further... Product mix up: a foil pouch labeled "Magnesium Sulfate in Water for Injection, 4 g/100 mL" actua... Class I Amneal Pharmaceuticals, LLC
Mar 17, 2026 Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, ... Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food ... Class II Teva Pharmaceuticals USA, Inc
Mar 17, 2026 Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, ... Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food ... Class II Teva Pharmaceuticals USA, Inc
Mar 17, 2026 Octreotide Acetate for Injectable Suspension, for gluteal intramuscular use, ... Lack of Assurance of Sterility: Quality system deficiencies identified during a routine U.S Food ... Class II Teva Pharmaceuticals USA, Inc
Mar 16, 2026 Cinacalcet Hydrochloride Tablets, 60 mg, 30 Tablets per bottle, Rx Only, Manu... CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit Class II Cipla USA, Inc.
Mar 16, 2026 Cinacalcet Hydrochloride Tablets, 90 mg, 30 Tablets per bottle, Rx Only, Manu... CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit Class II Cipla USA, Inc.
Mar 16, 2026 Cinacalcet Hydrochloride Tablets, 30 mg, 30 Tablets per bottle, Rx Only, Manu... CGMP Deviations; presence N-Nitroso Cinacalcet above the acceptable daily intake limit Class II Cipla USA, Inc.
Mar 13, 2026 Lanreotide Injection, 120 mg*/0.5 mL, Box contains 1 Pre-filled syringe and 1... Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for ... Class II Cipla USA, Inc.
Mar 13, 2026 Lanreotide Injection, 120 mg/0.5 mL, Box contains 1 Pre-filled syringe, Singl... Lack of Assurance of Sterility: Due to an FDA observation at the contract manufacturing site for ... Class II Cipla USA, Inc.
Mar 9, 2026 Icosapent Ethyl Capsules, 1 gram, 120 Capsules per bottle, Rx only, Manufactu... Failed Tablet/Capsule specifications: Red dots inside capsule and melted capsule caused by oxidiz... Class II Zydus Pharmaceuticals (USA) Inc
Mar 3, 2026 Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx ... Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-... Class II Rising Pharma Holding, Inc.
Mar 2, 2026 Children's Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) b... Presence of foreign substance: the firm received complaints for a gel-like mass and black particl... Class II STRIDES PHARMA INC
Feb 26, 2026 Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manuf... Subpotent Drug Class II MACLEODS PHARMA USA, INC
Feb 26, 2026 Semaglutide Inj, 2mg x 10, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W ... Lack of Assurance of Sterility Class II New Life Pharma LLC

Frequently Asked Questions

When a drug safety issue is identified, through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks, the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.

The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.

Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.